BIOQUAL, Inc. BIOQ
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -3,033.30% | -180.40% | 88.67% | 63.16% | 91.78% |
| Total Depreciation and Amortization | -5.44% | -7.63% | -9.12% | -2.77% | -87.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 57.72% | 41.00% | -46.81% | -- | -54.50% |
| Change in Net Operating Assets | -54.71% | 125.01% | 15.06% | 89.50% | 174.96% |
| Cash from Operations | -96.40% | 340.38% | -0.37% | 176.13% | 56.85% |
| Capital Expenditure | -298.76% | 100.00% | -2,285.93% | -- | 86.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,403.73% | -1,952.21% | -47,625.93% | -- | 86.48% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -102.30% | 255.80% | -233.07% | 166.98% | 63.67% |